Scientists are working on a drug based on a compound named YNT-185 that would keep narcolepsy and other sleep disorders at bay, reports Asian Scientist.
Researchers in the International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, have been trying to develop compounds that promote wakefulness and remedies narcolepsy. In 2015, they succeeded in synthesizing YNT-185, a non-peptide, selective and potent agonist for the orexin type-2 receptor.
